255
Participants
Start Date
October 31, 2013
Primary Completion Date
March 31, 2015
Study Completion Date
March 31, 2015
Plovamer acetate 0.5 milligram (mg)
Plovamer acetate was administered at a dose of 0.5 mg as weekly subcutaneous injection for 40 weeks up to a maximum of 14 months.
Copaxone 20 mg
Plovamer acetate was administered at a dose of 3 mg as weekly subcutaneous injection for 40 weeks up to a maximum of 14 months.
Plovamer acetate 3 mg
Plovamer acetate was administered at a dose of 10 mg as weekly subcutaneous injection for 40 weeks up to a maximum of 14 months.
Plovamer acetate 10 mg
Plovamer acetate was administered as two subcutaneous injection of 10 mg weekly for 40 weeks up to a maximum of 14 months.
Plovamer acetate 20 mg
Copaxone was administered at a dose of 20 mg as subcutaneous injection once daily for 40 weeks up to a maximum of 14 months.
Research site, Plainview
Research site, Willow Grove
Research site, Dover
Research site, Baltimore
Research site, Roanoke
Research site, Matthews
Research site, Charlotte
Research site, Wilmington
Research site, Hickory
Research site, Rome
Research site, Columbus
Research site, Pompano Beach
Research site, Miami
Research site, Sunrise
Research site, Naples
Research site, Sarasota
Research site, Nashville
Research site, Cincinnati
Research site, Dayton
Research site, Indianapolis
Research site, Golden Valley
Research site, Elk Grove Village
Research site, St Louis
Research Site, San Antonio
Research Site, Round Rock
Research site, San Diego
Research site, San Diego
Research site, Redding
Research Site, Detroit
Research site, Tacoma
Research site, Fairfield
Research site, New Bedford
Research site, Worcester
Research site, Detroit
Research site, Raleigh
Research site, Blagoevgrad
Research site, Dupnitsa
Research site, Sofia
Research site, Osijek
Research site, Varaždin
Research site, Zagreb
Research site, Brno
Research site, Havířov
Research site, Hradec Králové
Research site, Jihlava
Research site, Olomouc
Research site, Prague
Research site, Kuopio
Research site, Oulu
Research site, Turku
Research site, Athens
Research site, Thessaloniki
Research site, Budapest
Research site, Debrecen
Research site, Esztergom
Research site, Miskolc
Research site, Castelfiorentino
Research site, Catania
Research site, Cefalù
Research site, Milan
Research site, Modena
Research site, Montichiari
Research site, Parma
Research site, Roma
Research site, Cuautitlán Izcalli
Research site, León
Research site, Mexico City
Research site, México
Research site, Monterrey
Research site, Morelia
Research site, Tlalnepantla
Research site, Gdansk
Research site, Katowice
Research site, Lodz
Research site, Olsztyn
Research site, Poznan
Research site, Rzeszów
Research site, Warsaw
Research site, Krasnoyarsk
Research site, Kursk
Research site, Moscow
Research site, Nizhny Novgorod
Research site, Novosibirsk
Research site, Rostov-on-Don
Research site, Saint Petersburg
Research site, Saransk
Research site, Ufa
Research site, Yekaterinburg
Research site, Belgrade
Research site, Kragujevac
Research site, Niš
Research site, Cape Town
Research site, Durban
Research site, Pretoria
Research site, Aranjuez
Research site, Córdoba
Research site, Madrid
Research site, Móstoles
Research site, Santander
Research site, Zaragoza
Research site, Diyarbakır
Research site, Edirne
Research site, Istanbul
Research site, Kocaeli
Research site, Mersin
Research site, Samsun
Research site, Dnipropetrovsk
Research site, Ivano-Frankivsk
Research site, Kyiv
Research site, Lutsk
Research site, Simferopol
Research site, Vinnytsia
Research site, Zaporizhzhia
Research site, Exeter
Research site, Hull
Research site, Sheffield
Research site, Southampton
Research site, Stoke-on-Trent
Lead Sponsor
EMD Serono
INDUSTRY